This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing TAVR with a focus on the platforms from Medtronic and Edwards LifeSciences

Ticker(s): MDT, EW, ABT

Who's the expert?

Institution: UCLA Medical Center

  • Interventional cardiologist at UCLA , Medical Director of the Structural Heart Disease Program & Associate Clinical Professor of Medicine at the David Geffen School of Medicine.
  • Manages 25 patients with ATTR-CM.
  • Areas of expertise include coronary artery disease and structural and valvular heart disease while specializing in complex percutaneous coronary interventions including the use of rotational atherectomy. 

Interview Questions
Q1.

Describe your background and practice setting

Added By: ben_admin
Q2.

How many TAVR procedures do you conduct yearly?

Added By: ben_admin
Q3.

Which TAVR platforms do you currently utilize in your setting?

Added By: ben_admin
Q4.

Does the data presented at ACC2024 differentiate the Evolut platform from the Sapien?

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.